Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

ABP-2000 G-3

K-Number: K021029 · 2002-04-12

ApplicantBiotrac, Inc.
Decision Date2002-04-12
Product CodeDXN
Advisory CommitteeCV
DecisionSubstantially Equivalent

Device Summary

ABP-2000 G-3 is the device name listed in this FDA 510(k) record. The listed applicant is Biotrac, Inc.. It received FDA 510(k) clearance on 2002-04-12 under 510(k) number K021029. The device is classified under product code DXN. It was reviewed by the CV advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the ABP-2000 G-3?

ABP-2000 G-3 is a medical device that received FDA 510(k) clearance on 2002-04-12. The listed applicant is Biotrac, Inc.. The 510(k) number is K021029.

When did ABP-2000 G-3 receive FDA 510(k) clearance?

ABP-2000 G-3 received FDA 510(k) clearance on 2002-04-12, under 510(k) number K021029.

Who is the listed applicant for ABP-2000 G-3?

The FDA 510(k) record lists Biotrac, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for ABP-2000 G-3?

The FDA product code for ABP-2000 G-3 is DXN.

Related Devices (Code: DXN)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑